This study looked at the side effects of dapagliflozin (Farxiga) for patients with type 2 diabetes (T2D). It found that dapagliflozin was well tolerated and led to less kidney injury for patients with T2D.

This study examined if an intensive diet and exercise plan could reduce blood glucose levels and body weight of patients with early type 2 diabetes (T2D). The results showed that an intensive lifestyle change significantly reduced the number of patients with T2D and patients’ body weight.

This study examined the effectiveness and safety of biological therapy ranibizumab (Lucentis) for patients with diabetic macular edema (DME) that has never been treated. After one year, patients’ vision had improved significantly, particularly for patients who received 5 injections instead of 4.

This study examined which controlled blood glucose levels better in patients with type 1 diabetes (T1D) partaking in exercise – insulin pumps or a combination of insulin pumps and long-acting injections. The authors found that the combination was more effective for these patients.

This study investigated if a treat-to-target (T2T) strategy achieves remission in rheumatoid arthritis (RA). They found that following a T2T strategy leads to higher remission rates. 

This study compared patients with therapy-resistant high blood pressure (HBP) and type 1 diabetes (T1D) to those who treated HBP to examine if these patients had more health complications. The results showed that patients with resistant HBP had a greater chance of having worse T1D complications, heart disease, and stroke than those with treated HBP.

This study investigated recent developments in the management of rheumatoid arthritis (RA). 

This study looked at whether tocotrienol-rich vitamin E (Tocovid; TVE) can improve nerve function for patients with type 2 diabetes (T2D). It found that patients with diabetes taking TVE had improved nerve function.

This study investigated if garlic supplementation improves rheumatoid arthritis (RA) symptoms. They found that garlic supplementation improved RA inflammation and symptoms.

This study looked at how medications similar to the GLP-1 hormone affect heart health for patients with type 2 diabetes (T2D). It found that GLP-1-like medications did not significantly improve heart health, but reduced overall mortality.